CIBC Cuts Cronos Group (TSE:CRON) Price Target to C$17.00

Share on StockTwits

Cronos Group (TSE:CRON) had its price target reduced by CIBC from C$20.00 to C$17.00 in a research report released on Wednesday, BayStreet.CA reports.

CRON has been the topic of a number of other reports. BMO Capital Markets upgraded shares of Cronos Group from an underperform rating to a market perform rating and set a C$16.00 price objective on the stock in a report on Thursday, September 5th. Jefferies Financial Group lowered their price objective on shares of Cronos Group from C$15.00 to C$10.00 in a report on Friday, October 11th. Cowen lowered their price objective on shares of Cronos Group from C$21.00 to C$17.00 in a report on Tuesday, September 3rd. Finally, Canaccord Genuity upgraded shares of Cronos Group from a sell rating to a hold rating and boosted their target price for the stock from C$16.00 to C$17.00 in a report on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of C$18.56.

Shares of TSE CRON traded down C$0.58 during midday trading on Wednesday, reaching C$9.03. The company’s stock had a trading volume of 1,090,621 shares, compared to its average volume of 1,472,147. The company has a current ratio of 1.68, a quick ratio of 1.64 and a debt-to-equity ratio of 0.29. Cronos Group has a fifty-two week low of C$8.82 and a fifty-two week high of C$32.95. The stock has a market capitalization of $3.23 billion and a price-to-earnings ratio of 12.70. The stock has a 50 day simple moving average of C$11.25 and a 200-day simple moving average of C$16.95.

About Cronos Group

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Recommended Story: Why is cost of goods sold important?

Analyst Recommendations for Cronos Group (TSE:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.